Properties (50)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:acquisition |
gptkb:Johnson_&_Johnson
|
| gptkbp:aimsTo |
improve patient outcomes
|
| gptkbp:collaboratesWith |
research institutions
|
| gptkbp:develops |
cancer treatments
|
| gptkbp:employs |
medical professionals
researchers scientists |
| gptkbp:engagesIn |
clinical trials
|
| gptkbp:focusesOn |
oncology
|
| gptkbp:foundedIn |
2009
|
| gptkbp:hasAwards |
research grants
industry recognition innovation awards |
| gptkbp:hasCollaborationsWith |
academic institutions
biotech companies healthcare_organizations |
| gptkbp:hasPart |
sales department
R&D department marketing department |
| gptkbp:hasParticipatedIn |
gptkb:Asia
gptkb:Latin_America Europe |
| gptkbp:hasProductLine |
Erleada
Darzalex Zytiga Balversa Talvey |
| gptkbp:headquarters |
gptkb:Titusville,_New_Jersey
|
| https://www.w3.org/2000/01/rdf-schema#label |
Janssen Oncology
|
| gptkbp:isActiveIn |
global markets
clinical research drug commercialization |
| gptkbp:isFocusedOn |
cancer care
patient support programs oncology research |
| gptkbp:isInvolvedIn |
biotechnology
drug development pharmaceutical research |
| gptkbp:isKnownFor |
collaborative research
innovative therapies patient-centric approach |
| gptkbp:isLocatedIn |
gptkb:United_States
|
| gptkbp:isPartOf |
gptkb:Janssen_Pharmaceuticals
gptkb:Johnson_&_Johnson's_pharmaceutical_segment |
| gptkbp:offers |
immunotherapy
|
| gptkbp:partOf |
gptkb:Johnson_&_Johnson
|
| gptkbp:supports |
patient advocacy groups
cancer research initiatives healthcare education |